291
Participants
Start Date
February 28, 2011
Primary Completion Date
January 31, 2013
Study Completion Date
January 31, 2013
SAR110894
"Pharmaceutical form: Capsule~Route of administration: Oral"
placebo (for SAR110894)
"Pharmaceutical form: Capsule~Route of administration: Oral"
Donepezil
5 mg or 10 mg once daily continued as taken before inclusion
Investigational Site Number 036004, Randwick
Investigational Site Number 036005, Waratah
Investigational Site Number 036008, Heidelberg West
Investigational Site Number 036006, Herston
Investigational Site Number 036007, Chermside
Investigational Site Number 036009, Toowoomba
Investigational Site Number 036002, Adelaide
Investigational Site Number 036003, Woodville
Investigational Site Number 036001, Nedlands
Investigational Site Number 276011, Berlin
Investigational Site Number 840018, Cedarhurst
Investigational Site Number 250007, Marseille
Investigational Site Number 276001, Schwerin
Investigational Site Number 380002, Milan
Investigational Site Number 380001, Milan
Investigational Site Number 380003, Milan
Investigational Site Number 380004, Castellanza
Investigational Site Number 840031, Williamsburg
Investigational Site Number 724008, Madrid
Investigational Site Number 840039, Charlotte
Investigational Site Number 250002, Toulouse
Investigational Site Number 840004, Jacksonville
Investigational Site Number 840012, Orlando
Investigational Site Number 840015, Hialeah
Investigational Site Number 250004, Bordeaux
Investigational Site Number 840006, Miami
Investigational Site Number 840005, West Palm Beach
Investigational Site Number 840003, Delray Beach
Investigational Site Number 840014, Franklin
Investigational Site Number 840009, Hattiesburg
Investigational Site Number 724007, Seville
Investigational Site Number 250003, Nantes
Investigational Site Number 724002, Algorta
Investigational Site Number 250001, Lille
Investigational Site Number 380006, Ancona
Investigational Site Number 250008, Strasbourg
Investigational Site Number 840008, Baton Rouge
Investigational Site Number 840037, Tulsa
Investigational Site Number 250006, Paris
Investigational Site Number 840038, Austin
Investigational Site Number 276007, München
Investigational Site Number 276008, München
Investigational Site Number 840032, Phoenix
Investigational Site Number 840041, Gilbert
Investigational Site Number 250009, Limoges
Investigational Site Number 380005, Cefalù
Investigational Site Number 840026, Sherman Oaks
Investigational Site Number 840030, La Jolla
Investigational Site Number 840001, Redlands
Investigational Site Number 840024, Costa Mesa
Investigational Site Number 840002, Santa Ana
Investigational Site Number 840013, Fresno
Investigational Site Number 276009, Würzburg
Investigational Site Number 840034, Darien
Investigational Site Number 840011, Tampa
Investigational Site Number 840025, Quincy
Investigational Site Number 840040, Eatontown
Investigational Site Number 840021, Bennington
Investigational Site Number 124010, Calgary
Investigational Site Number 124015, Gatineau
Investigational Site Number 124009, Greenfield Park
Investigational Site Number 124014, Halifax
Investigational Site Number 124001, London
Investigational Site Number 124011, Montreal
Investigational Site Number 124008, Ottawa
Investigational Site Number 124013, Regina
Investigational Site Number 124003, Sherbrooke
Investigational Site Number 124006, St. John's
Investigational Site Number 124002, Toronto
Investigational Site Number 124004, Toronto
Investigational Site Number 250005, Nice
Investigational Site Number 276012, Dresden
Investigational Site Number 616004, Bydgoszcz
Investigational Site Number 616003, Gdansk
Investigational Site Number 616001, Gdynia
Investigational Site Number 616002, Poznan
Investigational Site Number 616006, Szczecin
Investigational Site Number 616005, Warsaw
Investigational Site Number 620002, Amadora
Investigational Site Number 620001, Lisbon
Investigational Site Number 724001, Barcelona
Investigational Site Number 724003, Terrassa
Lead Sponsor
Sanofi
INDUSTRY